Literature DB >> 18768837

B cell receptor affinity and B cell subset identity integrate to define the effectiveness, affinity threshold, and mechanism of anergy.

Ramiro Diz1, Suzanne K McCray, Stephen H Clarke.   

Abstract

In this study we show that BCR affinity and subset identity make unique contributions to anergy. Analysis of anti-Smith (Sm) B cells of different affinities indicates that increasing affinity improves anergy's effectiveness while paradoxically increasing the likelihood of marginal zone (MZ) and B-1 B cell differentiation rather than just follicular (FO) B cell differentiation. Subset identity in turn determines the affinity threshold and mechanism of anergy. Subset-specific affinity thresholds for anergy induction allow discordant regulation of low-affinity anti-Sm FO and MZ B cells and could account for the higher frequency of autoreactive MZ B cells than that of FO B cells in normal mice. The mechanism of anergy changes during differentiation and differs between subsets. This is strikingly illustrated by the observation that blockade of BCR-mediated activation of FO and MZ B cells occurs at different levels in the signaling cascade. Thus, attributes unique to B cells of each subset integrate with signals from the BCR to determine the effectiveness, affinity threshold, and mechanism of anergy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768837     DOI: 10.4049/jimmunol.181.6.3834

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Innate pathways to B-cell activation and tolerance.

Authors:  Steve P Crampton; Elisaveta Voynova; Silvia Bolland
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

2.  Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages.

Authors:  Mileka R Gilbert; Nikki J Wagner; Shannon Z Jones; Amanda B Wisz; Jose R Roques; Kristen N Krum; Sang-Ryul Lee; Volker Nickeleit; Chrys Hulbert; James W Thomas; Stephen B Gauld; Barbara J Vilen
Journal:  J Immunol       Date:  2012-06-06       Impact factor: 5.422

3.  Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM.

Authors:  Tâm D Quách; Nataly Manjarrez-Orduño; Diana G Adlowitz; Lin Silver; Hongmei Yang; Chungwen Wei; Eric C B Milner; Iñaki Sanz
Journal:  J Immunol       Date:  2011-03-11       Impact factor: 5.422

4.  The regulation of autoreactive B cells during innate immune responses.

Authors:  Barbara J Vilen; Jennifer A Rutan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

5.  Receptor cross-talk spatially restricts p-ERK during TLR4 stimulation of autoreactive B cells.

Authors:  Sang-Ryul Lee; Jennifer A Rutan; Andrew J Monteith; Shannon Z Jones; Sun Ah Kang; Kristen N Krum; Michelle A Kilmon; Jose R Roques; Nikki J Wagner; Stephen H Clarke; Barbara J Vilen
Journal:  J Immunol       Date:  2012-09-14       Impact factor: 5.422

6.  Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL.

Authors:  Stefano Iacovelli; Eva Hug; Sara Bennardo; Marcus Duehren-von Minden; Stefania Gobessi; Andrea Rinaldi; Mirza Suljagic; Daniel Bilbao; Giulia Bolasco; Julia Eckl-Dorna; Verena Niederberger; Francesco Autore; Simona Sica; Luca Laurenti; Hongsheng Wang; Richard J Cornall; Stephen H Clarke; Carlo M Croce; Francesco Bertoni; Hassan Jumaa; Dimitar G Efremov
Journal:  Blood       Date:  2015-01-06       Impact factor: 22.113

7.  Receptor editing and genetic variability in human autoreactive B cells.

Authors:  Julie Lang; Takayuki Ota; Margot Kelly; Pamela Strauch; Brian M Freed; Raul M Torres; David Nemazee; Roberta Pelanda
Journal:  J Exp Med       Date:  2015-12-22       Impact factor: 14.307

8.  Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia.

Authors:  Claudia Minici; Maria Gounari; Rudolf Übelhart; Lydia Scarfò; Marcus Dühren-von Minden; Dunja Schneider; Alpaslan Tasdogan; Alabbas Alkhatib; Andreas Agathangelidis; Stavroula Ntoufa; Nicholas Chiorazzi; Hassan Jumaa; Kostas Stamatopoulos; Paolo Ghia; Massimo Degano
Journal:  Nat Commun       Date:  2017-06-09       Impact factor: 14.919

9.  Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells.

Authors:  Andrew Getahun; Nicole A Beavers; Sandy R Larson; Mark J Shlomchik; John C Cambier
Journal:  J Exp Med       Date:  2016-04-25       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.